Project Grant HT94252510974
Award Date 10/15/25
Completion Date 10/14/27
Dollars Obligated $565K
Federal Agency
Awardee
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Rochester, MN 55905, USA
Similar Awards
- This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $564,900.00 to Mayo Clinic to support research aimed at "EXPLOITING VIRAL TROPISM TO TARGET CANCER-ASSOCIATED FIBROBLASTS IN INTRAHEPATIC CHOLANGIOCARCINOMA". The award period runs from September 1, 2024 to August 31, 2026. Mayo Clinic, a renowned non-profit academic medical center, will leverage its expertise in cancer biology, drug development,...
- This federal Project Grant award of $1,782,155 from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports advanced biomedical research by Mayo Clinic to identify novel drug targets for lethal prostate cancer using liquid biopsy. The 3-year project, commencing on April 1, 2025, aims to transform healthcare for military service members, veterans, and the broader public through innovative research addressing critical health challenges. As a...
- The federal Project Grant award of $161,400.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) will support Mayo Clinic's research project titled "AN ATLAS OF THE TUMOR IMMUNE CIRCULOME." This award, with a performance period from June 1, 2024 to May 31, 2025, aims to advance medical knowledge and improve patient care through innovative biomedical research. The Military Medical Research and Development program funds a wide range of...
- The Mayo Clinic has been awarded a $1,162,900 project grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, titled "LAUNCHING THE ERA OF MELANOMA SURVIVORSHIP: DEFINING TREATMENT TARGETS IN QUALITY OF LIFE AND MENTAL HEALTH", will fund advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The 3-year grant, running from July 2025 to July 2028, will...
- The Department of Defense's Defense Health Agency awarded a $322,800 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the Mayo Clinic in Rochester, Minnesota. The grant, with a performance period from April 1, 2024 to March 31, 2026, supports research on "MYELOPEROXIDASE PROMOTES PERSISTENT FIBROSIS." As a renowned non-profit academic medical center, Mayo Clinic will leverage its expertise in clinical care, biomedical research, and medical...
- Mayo Clinic was awarded a $8,966,819 project grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will support research from July 1, 2023 to June 30, 2027 to further develop purified exosome products for treating pulmonary damage from toxic exposures, leveraging Mayo Clinic's expertise in exosome applications. Through this funding, Mayo Clinic aims to advance biomedical solutions applicable to both military and civilian...
- This $424,565 Project Grant award, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports research focused on the clinical significance of somatic genetic variants in telomere biology disorders. The grant was awarded to Mayo Clinic, a renowned non-profit academic medical center, on September 1, 2025, with a planned completion date of August 31, 2028. Through this funding, Mayo Clinic will conduct advanced biomedical research to...
- The Mayo Clinic received a $278,250 project grant award from the Department of the Army Medical Command under the Military Medical Research and Development program. The grant will fund research from August 2021 through July 2025 to develop techniques for cytokine modulation of chimeric antigen receptor T cells to increase their safety and efficacy. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical research solutions...
- This federal Project Grant award from the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development) to Mayo Clinic provides $1,443,639.00 to investigate the molecular mechanisms underlying the ciliary trafficking of polycystins. The grant has an award date of April 1, 2024 and a planned completion date of March 31, 2028. This research seeks to advance the understanding of diseases related to ciliary dysfunction, which may have important implications for military medicine....
- The Defense Health Agency has awarded a $968,400 Project Grant to Mayo Clinic to develop a personalized approach to treating drug-resistant ovarian cancer. The grant, which began on June 1, 2024, and will run through May 31, 2028, is funded under the Military Medical Research and Development program (CFDA 12.420). This program supports biomedical research to improve the health and care of military service members, veterans, and their families. Through this award, Mayo Clinic will leverage its...